Back | Next |
home / stock / eq / eq message board
Subject | By | Source | When |
---|---|---|---|
$EQ great news | eastunder | investorshub | 04/20/2023 6:58:19 PM |
what do you make of this data? | MiamiGent | investorshub | 04/20/2023 2:42:20 AM |
I sold out a while ago to buy | jerseyboy | investorshub | 02/28/2021 5:14:44 AM |
I'm in this morning with a decent position. | jerseyboy | investorshub | 01/06/2021 5:57:53 PM |
znewcar1: EQ 41% v10,6M c6.18 f24,7M H6.39 | znewcar1 | investorshangout | 12/29/2020 9:23:22 PM |
But why? Why is it moving enough that | eastunder | investorshub | 12/29/2020 6:33:47 PM |
Nice bullish move today. | Actualfactual | investorshub | 12/29/2020 5:33:55 PM |
Live webcasts of both presentations will be available | eastunder | investorshub | 11/21/2020 10:46:54 PM |
Let me check for you. I'll see if | eastunder | investorshub | 11/21/2020 10:31:48 PM |
EQ is still just 1.5 x book value. | jimmy667 | investorshub | 11/20/2020 10:15:03 PM |
Looks like the investor conferences convinced a few | jimmy667 | investorshub | 11/20/2020 10:09:15 PM |
* * $EQ Video Chart 11-11-2020 * * | ClayTrader | investorshub | 11/11/2020 10:18:23 PM |
znewcar1: EQ 44% v36,1M c5.04 f24,2M H6.44 then sold off | znewcar1 | investorshangout | 11/11/2020 9:13:54 PM |
Emergency approval imminent | shurtha2000 | investorshub | 11/11/2020 5:50:12 PM |
Equillium to Present at Investor Conferences in November 2020 | eastunder | investorshub | 11/11/2020 5:32:01 PM |
Equillium Reports Third Quarter 2020 Financial Results and | eastunder | investorshub | 11/11/2020 5:25:04 PM |
EQ No but good alert, RN! | MiamiGent | investorshub | 11/10/2020 10:45:36 PM |
Any opinion on today's Q3-Filing updates. Don't find | RNsidersbuying | investorshub | 11/10/2020 10:40:03 PM |
Whats wrong with this pos?? | Roadtojourney | investorshub | 11/02/2020 9:09:13 PM |
Easy now children take it slow | Penny chatter | investorshub | 10/30/2020 4:05:36 PM |
News, Short Squeeze, Breakout and More Instantly...
Equillium Inc. Company Name:
EQ Stock Symbol:
NASDAQ Market:
More than 100 patients enrolled from over 100 clinical trial sites active in 12 countries Delivery of the interim data review to Ono Pharmaceutical Co. Ltd. (Ono) expected during Q3 will trigger Ono’s option exercise period Equillium, Inc. (Nasdaq: EQ), a clinical-sta...
$32.3 million cash balance at the end of Q1 2024 expected to provide cash runway into 2H 2025 Announced positive topline data from Phase 1b EQUALISE study of itolizumab in lupus nephritis patients, representing the first of two data sets that will trigger Ono Pharmaceutical’s optio...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...